This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management of non freezing cold injuries (NFCI)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

management of non freezing cold injuries

Management of NFCI include:

  • removing the affected limb and the patient from the cold and wet environment as quickly as possible

  • slow rewarming (at 37–39°C ) is used as opposed to rapid rewarming seen in freezing cold injuries
    • rewarming should be carried out through exposure to warm air alone
    • NFCI must not be immersed in water

  • analgesia
    • amitriptyline with or without pregabalin (traditional opiods and NSAIDs and gabapentin do not have the same efficacy)
      • titrate upward as necessary
    • regional analgesia - temporary relief can be achieved through spinal or epidural analgesia

  • medical or surgical sympethectomy should be avoided since it is associated with medium- to long-term deterioration in patient symptoms

  • surgery - should be delayed till the extent of the injury is understood (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.